Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial.
López-Cortés LE, Rosso-Fernández C, Núñez-Núñez M, Lavín-Alconero L, Bravo-Ferrer J, Barriga Á, Delgado M, Lupión C, Retamar P, Rodríguez-Baño J; SIMPLIFY Study Group. López-Cortés LE, et al. BMJ Open. 2017 Jun 9;7(6):e015439. doi: 10.1136/bmjopen-2016-015439. BMJ Open. 2017. PMID: 28601833 Free PMC article. Clinical Trial.
Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications.
Núñez-Núñez M PharmD, MsC, Casas-Hidalgo I, García-Fumero R, Vallejo-Rodríguez I, Anguita-Santos F, Hernández-Quero J, Cabeza-Barrera J, Ruiz-Sancho A. Núñez-Núñez M PharmD, MsC, et al. Eur J Hosp Pharm. 2020 Sep;27(5):310-312. doi: 10.1136/ejhpharm-2018-001711. Epub 2018 Nov 26. Eur J Hosp Pharm. 2020. PMID: 32839266 Free PMC article.
Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain.
Núñez-Núñez M, Perez-Galera S, Girón-Ortega JA, Sandoval Fernández-Del-Castillo S, Beltrán-García M, De Cueto M, Suárez-Barrenechea AI, Palacios-Baena ZR, Terol-Barrero P, Oltra-Hostalet F, Arenzana-Seisdedos Á, Rodriguez-Baño J, Retamar-Gentil P. Núñez-Núñez M, et al. Front Pharmacol. 2022 Oct 10;13:1018158. doi: 10.3389/fphar.2022.1018158. eCollection 2022. Front Pharmacol. 2022. PMID: 36299899 Free PMC article.
Dalbavancin or oritavancin for skin infections.
Núñez-Núñez M, Rodríguez-Baño J. Núñez-Núñez M, et al. N Engl J Med. 2014 Sep 18;371(12):1160. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229923 No abstract available.
Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review.
Núñez-Núñez M, Navarro MD, Gkolia P, Babu Rajendran N, Del Toro MD, Voss A, Sharland M, Sifakis F, Tacconelli E, Rodríguez-Baño J; Members of the EPI-NET group on behalf of COMBACTE-MAGNET Consortium. Núñez-Núñez M, et al. BMJ Open. 2017 Mar 27;7(3):e014538. doi: 10.1136/bmjopen-2016-014538. BMJ Open. 2017. PMID: 28348192 Free PMC article.
The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.
Núñez-Núñez M, Navarro MD, Palomo V, Rajendran NB, Del Toro MD, Voss A, Sharland M, Sifakis F, Tacconelli E, Rodríguez-Baño J; EPI-Net, Combacte-Magnet and EUCIC Group for SUSPIRE. Núñez-Núñez M, et al. Clin Microbiol Infect. 2018 Feb;24(2):105-109. doi: 10.1016/j.cmi.2017.07.014. Epub 2017 Jul 24. Clin Microbiol Infect. 2018. PMID: 28750921 Free article. Review.
39 results